Funding Details
- Awarder
- RSS - www.geekwire.com
- Date Award
- July 15, 2024
- Vertical
- Health/Life Sciences
- Funding URL
- View Funding Page
- Valuation
-
$120,000,000
Company Info
- Founding Year
- 2020
- Traction
- Aurion Biotech recently completed a Phase 1 / 2 clinical trial with 97 patients in the U.S. and Canada. The company's cell therapy has also been approved for use in Japan.
- Organizations Involved
- CorneaGen, Kyoto Prefecture University of Medicine
- Founders
- Greg Kunst
- Company Description
- Aurion Biotechnologies is a clinical-stage biotech company.
- Market
- Vision Restoration
- Location
-
Seattle,
WA,
US
- Coinvestors
- None
Links